GDF15, which is also known as Macrophage Inhibitory Cytokine 1 (MIC-1), has been shown to be upregulated in several aggressive tumor types such as glioblastoma, pancreatic, breast and colorectal cancers and it has been correlated with poor prognosis and patient survival13–16. This evidence concerns the gene GDF15 and neoplasm.